SCHEDULE: Laurence Lytton Discloses 6.4% Stake in MDxHealth SA

Laurence W. Lytton has filed an amended Schedule 13G, reporting beneficial ownership of 6.4% of MDxHealth SA's Ordinary Shares as of September 30, 2025.

Summary

• Laurence W. Lytton beneficially owns 3,163,286 Ordinary Shares of MDxHealth SA.
• This ownership represents 6.4% of the company's outstanding Ordinary Shares.
• The percentage is calculated based on 49,497,334 Ordinary Shares outstanding as of December 31, 2024, as reported in the Issuer's Form 20-F.
• Lytton holds sole voting and dispositive power over 3,149,548 shares.
• Shared voting and dispositive power is held over 13,738 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previously reported beneficial ownership.

Sentiment

Score: 5

Explanation: The filing is a standard beneficial ownership report (Schedule 13G Amendment No. 2) disclosing a significant stake in MDxHealth SA. It is factual and does not contain information that would inherently be positive or negative without further context of previous filings or market expectations.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant ownership stake held by Laurence W. Lytton, which can influence market perception and potentially signal confidence or a long-term interest in the company.

Key Dates

Keywords

MDxHealth SA, Laurence W. Lytton, Schedule 13G, Beneficial Ownership, Ordinary Shares, Shareholder, SEC Filing, Investment